vegf tki therapy in the adjuvant setting of rcc
Published 7 years ago • 305 plays • Length 7:18Download video MP4
Download video MP3
Similar videos
-
4:27
vegf-tki therapy in first-line mrcc
-
2:14
dr. haas on adjuvant vegf-targeted therapy in rcc
-
0:45
dr. mcdermott on the role of vegf targeted therapy in rcc
-
1:50
dr. gong on adverse events of tki vegf-directed therapy in rcc
-
1:15
dr. figlin on toxicity profile of immunotherapy/vegf tki combinations in rcc
-
4:09
favorable-risk rcc: options for vegf tki monotherapy
-
5:01
vegf tki therapy after i/o in mrcc
-
5:15
favorable-risk rcc: frontline vegf tki/io combinations
-
6:50
adjuvant therapy in resected high-risk renal cell carcinoma
-
1:54
dr. figlin on tki therapy options in renal cell carcinoma
-
2:32
adjuvant therapy in rcc - dr. andre fay (english version)
-
5:11
selecting immunotherapy versus vegf tki for mrcc
-
0:54
advances in the development of targeted therapies for renal cell carcinoma
-
3:39
anti-vegf/immunotherapy combinations in kidney cancer
-
3:31
vegf targeted therapy and chemo an active combination in rapidly progressive renal cell carcinoma
-
10:38
considerations for using adjuvant therapy in mrcc
-
7:43
mrcc: resistance to vegf and i/o
-
8:07
vegf tki immunotherapy combinations for mrcc
-
4:59
strategies for managing vegf-tki toxicities